HH

Howard.d Hai

Interim Director of Strategy, Chief of Staff at Perpetual Medicines

Shanghai

Overview 

Howard.D Hai is a Vice President at Gordian Ventures, specializing in venture capital investments in biotech, with a focus on seed and pre-seed stages. With a background in entrepreneurship and new venture formation, he has held senior roles at Chengwei Capital and Perpetual Medicines, contributing to the growth and success of various startups in the biotech sector. Notable highlights of Howard.D Hai's career include his leadership roles at Gordian Ventures and Chengwei Capital, where he has played a key role in identifying and investing in promising biotech startups, as well as his experience in strategy and operations at Perpetual Medicines, showcasing a well-rounded expertise in the biotech industry.

Work Experience 

GV

Gordian Ventures

  • Vice President, Investment

    2023 - Current

  • Senior Associate, Investment

    2022 - 2023

    Gordian Ventures is a global life sciences venture firm focused on the incubation of companies with extremely high technical barriers to entry. As co-founders, Gordian Ventures works side-by-side with scientist-entrepreneurs whose insights about overcoming technical barriers are often beyond the scope of the traditional biotech funding model. Our role as active co-founders enables Gordian Ventures to provide embedded, hands-on expertise critical to aligning novel concepts and building visionary companies. We collaborate with our scientific co-founders in the quest to surmount previously unbreakable technical barriers and combat previously intractable diseases that have plagued mankind for millennia. Delivering new age solutions to age-old problems means thinking beyond the limitations of a conventional “magic pill” development cycle of identifying a biology, selecting a target, and attempting to produce a drug to resolve a specific aspect of biology. Gordian Ventures and our scientific co-founders are investing in a new archetype to build companies capable of solving the healthcare problems of today and tomorrow. We are moving at a rapid pace beyond frameworks limited to biology and chemistry and are forging ahead to explore uncharted science at the intersections of multiple technologies to create a healthier future for the people of our planet.

Gordian Ventures is a global life-sciences incubator that co-founds companies with insurmountable technological barriers to entry.

gordianvc.com
CC

Chengwei Capital

  • Vice President

    2023

  • Senior Associate

    2022 - 2023

PM

Perpetual Medicines

  • Interim Director of Strategy, Chief of Staff

    2023

PB

Pivotal Bioventure China

  • Investor

    2022 - 2022

VB

Viva BioInnovator

  • Investor

    2020 - 2022

    Focus on early-stage pre-clinical therapeutics investment opportunities worldwide. Specify in novel biotechnology platform, FIC small molecule/biologics, and cell/gene therapy. Provide cash and in-kind services (equity-for-service).

PM

PwC Mainland China and Hong Kong

  • Senior Associate

    2018 - 2020

    - Financial Service - PE/VC Group - Focus on healthcare PE/VC funds - Due Diligence, portfolio valuation, statutory audit, etc.

BC

Boston Consulting Group (BCG)

  • Assistant Consultant

    2017 - 2018

BCG Securities focuses on wealth management with high net worth individuals.

bcg.com

Education 

Articles About Howard.d

Relevant Websites